Close Menu

NEW YORK – A federal judge has shut down a lawsuit that alleged a wide-ranging conspiracy to steal and profit off technology used in DNA microarrays.

In 2018, three researchers led by Monib Zirvi, an instructor at Weill Cornell Medicine, filed suit against Illumina, Applied Biosystems (now part of Thermo Fisher Scientific), Affymetrix, and certain individuals in the genomics industry, alleging they had stolen trade secrets, committed racketeering, submitted false and misleading patent applications, and breached fiduciary duties, among other allegations.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The head of Operation Warp Speed tells Bloomberg he expects the paused AstraZeneca and Johnson & Johnson vaccine trials to resume soon.

A new UK government says socioeconomic factors, not genetics, account for disparities in deaths due to COVID-19 between ethnic groups, the Financial Times reports.

NPR reports on an Alzheimer's disease drug trial that is continuing despite the pandemic.

In Nature this week: CRISPR-Cas3 system for making large deletions efficiently, more.